Silencing of integrated human papillomavirus-16 oncogenes by small interfering RNA-mediated heterochromatization

Molecular Cancer Therapeutics

Volumn 9, Issue 7, 2010, Pages 2114-2122

  Palanichamy, Jayanth Kumar ^a   Mehndiratta, Mohit ^a   Bhagat, Mohita ^a   Ramalingam, Pradeep ^a   Das, Brati ^a   Das, Prerna ^a   Sinha, Subrata ^a   Chattopadhyay, Parthaprasad ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; NUCLEAR FACTOR I; PROTEIN E6; PROTEIN E7; PROTEIN P53; SMALL INTERFERING RNA; SMALL INTERFERING RNA 1; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; CHROMATIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; HETEROCHROMATIN; HISTONE; LYSINE; NEUROFIBROMIN; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ARTICLE; BINDING SITE; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; APOPTOSIS; CHROMATIN; ENHANCER REGION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HELA CELL LINE; HETEROCHROMATIN; METABOLISM; METHYLATION; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN; ENHANCER ELEMENTS, GENETIC; HELA CELLS; HETEROCHROMATIN; HISTONES; HUMAN PAPILLOMAVIRUS 16; HUMANS; LYSINE; METHYLATION; NEUROFIBROMIN 1; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954568176     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-09-0977     Document Type: Article

References (40)

1. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008;168:123-37.
2. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in India, 2010.
3. Alani RM, Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol 1998;16:330-7.
4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
5. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009;384:260-5.
6. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer.Lancet 2007;370:890-907.
7. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
8. zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999;111:581-7.
9. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495-505.
10. Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteosome pathway. Cancer Res 1996;56:4620-4.
11. Goodwin EC, DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A 2000;97:12513-8.
12. Horner SM, DeFilippis RA, Manuelidis L, DiMaio D. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerasein-dependent senescence and apoptosis in HeLa cervical carcinoma cells. J Virol 2004;78:4063-73.
13. Johung K, Goodwin EC, DiMaio D. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 2007;81:2102-16.
14. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003;22:5938-45.
15. Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002;21:6041-8.
16. Yamato K, Yamada T, Kizaki M, et al. New highly potent and specific E6 and E7 siRNAs for treatment of HPV-16 positive cervical cancer. Cancer Gene Ther 2008;15:140-53.
17. Yoshinouchi M, Yamada T, Kizaki M, et al. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther 2003;8:762-8.
18. Koivusalo R, Mialon A, Pitkänen H, Westermarck J, Hietanen S. Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists. Cancer Res 2006;66:11817-24.
19. Morris KV. Curr Top Microbiol Immunol 2008;320:211-24.
20. Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004;305:1289-92.
21. Ting AH, Schuebel KE, Herman JG, Baylin SB. Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat Genet 2005;37:906-10.
22. Han J, Kim D, Morris KV. Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc Natl Acad Sci U S A 2007;104:12422-7.
23. Suzuki K, Juelich T, Lim H, et al. Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region. J Biol Chem 2008;283:23353-63.
24. Hawkins PG, Santoso S, Adams C, Anest V, Morris KV. Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res 2009;37:2984-95.
25. Stünkel W, Bernard HU. J Virol 1999;73:1918-30.
26. Donzé O, Picard D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res 2002;30:e46.
27. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
28. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
29. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007;35:e41.
30. Weinmann AS, Plevy SE, Smale ST. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. Immunity 1999;11:665-75.
31. Haring M, Offermann S, Danker T, Horst I, Peterhansel C, Stam M. Chromatin immunoprecipitation: optimization, quantitative analysis and data normalization. Plant Methods 2007;3:11.
32. Chalk AM, Sonnhammer EL. siRNA specificity searching incorporating mismatch tolerance data. Bioinformatics 2008;24:1316-7.
33. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003;5:834-9. (Pubitemid 37087172)
34. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 2004;101:1892-7.
35. Napoli S, Pastori C, Magistri M, Carbone GM, Catapano CV. Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J 2009;28:1708-19.
36. Hall IM, Shankaranarayana GD, Noma K, Ayoub N, Cohen A, Grewal SI. Establishment and maintenance of a heterochromatin domain. Science 2002;297:2232-7.
37. Core LJ, Waterfall JJ, Lis JT. Nascent RNA sequencing reveals wide-spread pausing and divergent initiation at human promoters. Science 2008;322:1845-8.
38. Preker P, Nielsen J, Kammler S, et al. RNA exosome depletion reveals transcription upstream of active human promoters. Science 2008;322:1851-4.
39. Seila AC, Calabrese JM, Levine SS, et al. Divergent transcription from active promoters. Science 2008;322:1849-51.
40. Hong D, Lu W, Ye F, Hu Y, Xie X. Gene silencing of HPV-16 E6/E7 induced by promoter-targeting siRNA in SiHa cells. Br J Cancer 2009;101:1798-804.